Minerva Surgical, Inc. (UTRS): Price and Financial Metrics
UTRS Price/Volume Stats
| Current price | $0.00 | 52-week high | $0.00 |
| Prev. close | $0.00 | 52-week low | $0.00 |
| Day low | $0.00 | Volume | 100 |
| Day high | $0.00 | Avg. volume | 350 |
| 50-day MA | $0.00 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 0.89K |
UTRS Stock Price Chart Interactive Chart >
Minerva Surgical, Inc. (UTRS) Company Bio
Minerva Surgical Inc., a commercial-stage medical technology company, focuses on developing, manufacturing, and commercializing minimally invasive solutions to meet the uterine healthcare needs of women. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists across various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
UTRS Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 0.00% |
| 5-year | N/A |
| YTD | N/A |
| 2024 | 0.00% |
| 2023 | 423.72% |
| 2022 | -95.65% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...